Rockwell Medical reported second quarter 2026 net sales of $17.8 million, an 11% increase year-over-year, with gross margin expanding to 18%. The company generated $2.1 million in operating cash flow and ended the quarter with $24.8 million in cash. This filing announces a 1-for-10 reverse stock split that became effective on July 1, 2026, allowing the company to regain compliance with Nasdaq's minimum bid price requirement. Rockwell Medical operates in the healthcare industry, developing and distributing hemodialysis products.
